DMD Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on April 28, 2005; DOI: 10.1124/dmd.105.004655


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.105.004655v1
33/8/1254    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koyano, S.
Right arrow Articles by Sawada, J.-i.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koyano, S.
Right arrow Articles by Sawada, J.-i.


Received for publication March 8, 2005.
Revised April 27, 2005.
Accepted for publication April 27, 2005.

Functional analysis of six human aryl hydrocarbon receptor variants in a Japanese population

Satoru Koyano 1*, Yoshiro Saito 1, Hiromi Fukushima-Uesaka 1, Seiichi Ishida 1, Shogo Ozawa 1, Naoyuki Kamatani 2, Hironobu Minami 3, Atsushi Ohtsu 3, Tetsuya Hamaguchi 4, Kuniaki Shirao 4, Teruhiko Yoshida 4, Nagahiro Saijo 3, Hideto Jinno 1, Jun-ichi Sawada 1

1 National Institute of Health Sciences 2 Tokyo Women's Medical Unversity 3 National Cancer Center Hospital East 4 National Cancer Center

* Address correspondence to: E-mail: skoyano{at}nihs.go.jp

Abstract

Aryl hydrocarbon receptor (AhR) is an important transcriptional regulator involved in the induction of CYP1A1, CYP1A2, CYP1B1, UGT1A1, and UGT1A6. In this study, functional properties of four novel naturally occurring human AhR variants (K401R, N487D, I514T, and K17T/R554K) were examined along with the single variants, K17T and R554K. The luciferase reporter assay using the CYP1A1 promoter reporter in HeLa cells treated with {beta}-naphthoflavone or 3-methylcholanthrene, which are known as typical agonists for AhR, showed that reporter activities of the K401R and N487D variants were reduced to 40-58% of those of wild type but not of the other variants. Similarly, the K401R and N487D variants also reduced the omeprazole-induced reporter activities to approximately 56% and 74% of those of the wild type (WT), respectively. The reduced activities of the two variants were probably caused by the reduced protein expression levels, since the protein levels of the K401R and N487D variants were approximately 52% and 47% of the WT, respectively, without any changes in their mRNA levels. The reduced protein levels were recovered by treatment with a proteasome inhibitor MG-132, suggesting that the reduced protein levels were caused by the accelerated proteasomal degradation by a proteasome. Taken together, the current data demonstrate that the K401R and N487D variants reduce their apparent transcriptional activities, both ligand-induced and omeprazole-induced activation, probably through reduced protein expression. Thus, these two variants may influence drug metabolism through reduced induction of CYP1A1 and other target enzymes.


Key words: Ah receptor, ARNT, CYP gene regulation, CYP induction, CYP1A, cytochrome P450, genetic polymorphism, transcriptional regulation


This article has been cited by other articles:


Home page
Toxicol SciHome page
A. B. Okey
An Aryl Hydrocarbon Receptor Odyssey to the Shores of Toxicology: The Deichmann Lecture, International Congress of Toxicology-XI
Toxicol. Sci., July 1, 2007; 98(1): 5 - 38.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Dragin, T. P. Dalton, M. L. Miller, H. G. Shertzer, and D. W. Nebert
For Dioxin-induced Birth Defects, Mouse or Human CYP1A2 in Maternal Liver Protects whereas Mouse CYP1A1 and CYP1B1 Are Inconsequential
J. Biol. Chem., July 7, 2006; 281(27): 18591 - 18600.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.